OliX Pharmaceuticals signs agreement with LGC to accelerate production of asymmetric siRNA for the treatment of Sub-Retinal Fibrosis and Wet Macular Degeneration

News - LGC will produce active pharmaceutical ingredients for preclinical and clinical study of OLX301D programme

16 June 2020
LGC and Q2 Solutions announce global bioanalytical strategic partnership

News - Will each contribute extensive experience and capabilities in small and large molecule bioanalysis to support customer-centric approach

26 June 2020
Year in Industry Placement – Charlotte Banfield

Blog - Placement student Charlotte Banfield describes her year of industry with LGC's Drug Development Services team, including her successes and insights

08 October 2020
LGC offers regulated bioanalysis on the SCIEX TripleTOF® 6600 High-Resolution Mass Spectrometry platform

News - Platform offers alternative tool for quantification of therapeutics and biomarkers from within complex biological matrices

25 November 2020